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P U B L I S H E D B Y E L S E V I E R I N C .LETTERS TO THE EDITORMultiple Simultaneous Plaque Erosion in
3 Coronary ArteriesWe performed optical coherence tomography (OCT)
imaging with matched histology in a 34-year-oldFIGURE 1 Multiple Plaque Erosions in 3 Major Coronary Arteries
(A) Postmortem radiography showed focal mild calciﬁcation in all major
circumﬂex artery (LCX) with a nonocclusive platelet-rich organizing thro
artery (RCA) showed a luminal ﬁbrin-rich organizing thrombus with an u
showed a luminal ﬁbrin-rich organizing thrombus with an underlying path
are shown. Fibrin-rich thrombus with a few inﬂammatory cells are seen
optical frequency domain imaging images (OFDI) (Terumo, Tokyo, Japan
circumference of the vessel (red arrows); however, the culprit site (whit
macrophage in the diagonal branch (macrophages stained section of D).
because the thrombus had focal areas of platelets interspersed by large a
bright layer with attenuation (red arrowheads) indicates presence of m
hematoxylin and eosin (H&E), platelet ([PLT] CD61), ﬁbrin (ﬁbrin II), and
Platelet stains (brown) show few superﬁcial and interspersed platelets
macrophage inﬁltration (brown). *Placement of the guidewire. L ¼ lumman with history of smoking and untreated hyper-
lipidemia who had suffered from epigastric pain and
was found dead at home. Multiple plaque erosions in
3 major coronary arteries were discovered (Figure 1).
Plaque erosion is suspected in the presence of an
acute luminal thrombus that is in direct contact with
the underlying intima comprising smooth muscle
cells and proteoglycan with an absence of endothelial
lining (1). The erosive plaques are rich in versican,coronary arteries. (B) Histologic examination showed the left
mbus (Th) with underlying late ﬁbroatheroma. (C) The right coronary
nderlying late ﬁbroatheroma. (D) The diagonal branch artery also
ological intimal thickening. High-power images from boxes in C and D
on the luminal surface. Corresponding macrophage (MF) stain and
) are depicted. Moderate macrophage inﬁltration is seen around the
e arrows) is devoid of macrophages in the RCA. Note the absence of
OFDI showed luminal surface irregularity with minimal attenuation
reas of ﬁbrin in the RCA and the diagonal branch (white arrows), and a
acrophages in RCA (C). (E) Serial sections at high-power stained by
macrophage (CD68) stained images from the box in D are shown.
with a predominance of ﬁbrin (brown, adjacent section) and rare
en; LAD ¼ left anterior descending; NC ¼ necrotic core.
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1173hyaluronan, and type III collagen, unlike rupture or
stable plaques, which are rich in type I collagen (2).
The erosion lesions are more often eccentric and
infrequently calciﬁed; they show minimal
inﬂammation with a few or absent macrophages and
T-lymphocytes (2). The media underneath plaque
erosions are similar to plaques with mild stenosis,
rich in smooth muscle cell actin, which is also
highly expressed in intimal smooth muscle cells in
erosions. Plaque erosions often show negative
remodeling. It is likely that spasm may play an
important role in plaque erosion.
Plaque erosion accounts for 25% to 35% of coronary
thrombi in patients dying of acute myocardial
infarction and/or sudden coronary death (1). Plaque
erosions occur in individuals with relatively low
total cholesterol, higher high-density lipoprotein
cholesterol, and low total cholesterol /high-density
lipoprotein cholesterol ratio as compared to plaque
rupture (1). Consistently, smoking is an important
risk factor of plaque erosion in men and women
dying of sudden coronary death (1). Also, plaque
erosions are observed with greater frequency in
women, less percentage of stenosis, less
calciﬁcation, and less plaque burden (1). Plaque
erosion accounts for over 80% of thrombi in
women <50 years of age, with less frequency in
older women (>50 years). Severe narrowing (>75%
cross-sectional area narrowing) is only observed in
40% of plaque erosions whereas 48% show 51% to
75% luminal narrowing and only 12% of erosions
have <50% narrowing. Necrotic core area follows
the same trends with the least number of areas seen
in those with less stenosis, and macrophage
inﬁltration in similar irrespective of the degree of
stenosis.
At the time of presentation, 88% of plaque erosions
show healing—nuclear breakdown, proliferation of
smooth muscle and endothelial cells—as compared to
54% of ruptured plaques (p < 0.0001). Thrombus is
almost always organizing in less stenotic lesions as
compared to severely stenotic erosions, which show
the least thrombus organization. In 96% of cases,
plaque erosion is observed at a single site within the
coronary tree, whereas 4% of cases show multiple
sites of erosion. The underlying plaque morphology
consists of either pathological intimal thickening or
ﬁbroatheroma (pathological intimal thickening 16%,
early ﬁbroatheroma 50%, and late ﬁbroatheroma
34%); the media show intact internal elastic lamina
and external elastic lamina in 32% of cases, focally
disrupted IEL (from inﬂammation and angiogenesis)
in 52%, and, uncommonly, both IEL and EEL dis-
rupted in 16% of cases. The majority of erosionlesions show no calciﬁcation (56%); microcalciﬁcation
is observed in 40%, whereas fragmented and sheets
of calciﬁcation are seen in 2%, each. Inﬂammation is
usually absent or minimal in 68% of cases within the
transition zone between thrombus and underlying
plaque and mild in 32%. Furthermore, inﬂammation
at the adventitial medial border is absent or minimal
in 34%, mild in 50%, and rarely moderate or severe in
18% of cases (14% and 4%, respectively) (1).
Until recently it was not possible to identify pla-
que erosion in living patients. With the advent of
OCT, it has become possible to differentiate the
acute coronary events resulting from the underlying
plaques with ruptured ﬁbrous caps or intact ﬁbrous
caps (3). A deﬁnite diagnosis of plaque erosion
requires the presence of an acute luminal thrombus
with a nonruptured visualized plaque (4). Probable
OCT erosion was deﬁned as luminal surface
irregularity or attenuation of underlying plaque by
thrombus without superﬁcial lipid or calciﬁcation at
the adjacent proximal or distal sections. OCT-
deﬁned plaque erosion occurs in 31% of patients
presenting with acute coronary syndromes. It has
been proposed that the acute event associated with
intact ﬁbrous caps may not need to be treated with
balloon dilation or stent implantation if the lumen
is not critically compromised (5). These patients
may be left alone after the thrombus aspiration on
dual antiplatelet agents. However, no distinct
plaque morphologic features of erosion-prone
plaques have been identiﬁed. These ﬁndings allude
to the necessity to reconsider differences in the
mechanism of thrombosis between erosion versus
rupture, and that perhaps different strategies are
required for their treatment because in only 40% of
cases is severe stenosis identiﬁed.Kazuyuki Yahagi, MD
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Tomography Images of Bioabsorbable StentsFlare spots (Figures 1A and 1B) are observed in
intravascular optical coherence tomography (IVOCT)
images of bioabsorbable stent struts in patients and
have no analog in metallic stents. Gutiérrez-Chico
et al. (1) proposed that ﬂare spots were located at
hinge points where the highest strain is experienced
during deployment, suggesting that they represent
micro-crazes (ﬁne lines) in the polymer.
Nonetheless, the mechanism for the presence of
ﬂare spots in IVOCT images, and the large variation
in their appearance where no two are alike, is not
known. In this study, micro-CT and IVOCT images of
a bioabsorbable stent deployed in a cylindrical
phantom blood vessel were coregistered and
compared in order to investigate the underlying
mechanism for presence of ﬂare spots in IVOCT
images.
A 3-mm lumen diameter phantom vessel was made
out of polydimethylsiloxane with elastic properties
comparable to that of arteries. Titanium dioxide was
added to polydimethylsiloxane to simulate the light-
scattering properties of the arterial wall. A 3.0  18
Absorb stent (Abbott Vascular, Santa Clara, California)
was deployed within the phantom vessel at 16-atm
pressure with a balloon while submerged in a water
bath at body temperature (37C) to minimize any
structural changes to the polymer. IVOCT images of
the Absorb stent (Figures 1C and 1D) were acquiredusing a frequency domain IVOCT system (CorVue,
Volcano Corporation, San Diego, California) while
the phantom vessel was ﬂushed with saline. The
IVOCT catheter was pulled back at a slow speed of
1.5 mm/s over a 15-mm length of vessel recording at
a rate of 30 frames/s. After stent deployment and
IVOCT imaging, micro-CT images of the phantom
vessel at resolution of 6 mm were recorded as a gold
image standard. Each recorded IVOCT image was
registered to a sequence of 8 micro-CT images due
to the spiral pattern associated with a pullback and
relatively larger longitudinal spacing between
IVOCT images. Figure 1 illustrates 2 successive
IVOCT images (Figures 1C and 1D) along with the
corresponding coregistered micro-CT images
(Figures 1E and 1F). The change in appearance of
groups of struts (indicated with green and yellow
ovals) can be observed in successive IVOCT and
micro-CT images. From the micro-CT image
sequence (Figures 1E and 1F), adjacent struts are
observed to merge (separate) at the arterial side of
the stent and form a micro-sized gap at the vessel
wall, with a different appearance at every gap. Flare
spots in the IVOCT images are only generated when
gaps appear in the micro-CT images on the arterial
side.
The micro-CT dataset was used to create a
3-dimensional representation of the entire stent
demonstrating that micro-crazes are formed on the
arterial side of the stent and therefore result in micro-
gaps at the vessel wall. There were 2 types of crazing,
which correspond to locations where 2 or 3 struts
merge (separate). During a pullback, the IVOCT beam
propagates through the vessel lumen, where portions
of light reﬂect from and transmit across the strut
edge. Light reﬂected from the strut edge forms an
outline of the outer surface of the strut in IVOCT
images. When the IVOCT beam enters a gap region
with micro-crazes, reﬂections at the gap boundary
occur before light returns to the catheter. The re-
ﬂections at gap boundaries produce ﬂare spots of
higher intensity inside struts in IVOCT images
(Figure 1G). Because each crazing site is different at
every hinge point, as demonstrated by the micro-CT
images (Figures 1E and 1F), the pattern of light
reﬂections is expected to vary, which is consistent
with the observation that no two ﬂare spots appear
identical in recorded IVOCT images.
In conclusion, we have completed imaging exper-
iments of an Absorb stent deployed in a phantom
vessel to investigate the origin of ﬂare spots observed
in IVOCT images of bioabsorbable stents. Flare spots
observed in IVOCT images correspond to gaps
observed in micro-CT images formed by micro-crazes
